NDC 60505-0191-4 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0191
- Requested NDC
- 60505-0191-4
- Package NDCs from labels
- 60505-0191-3, 60505-0191-0, 60505-0191-1, 60505-0191-8, 60505-0191-4
- Manufacturer
- Apotex Corp.
- Effective date
- 2019-08-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride - Apotex Corp. | Apotex Corp. | 2019-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0191-0 | EA - Each | 60505-0191 | a6aa7f05-66b6-43f1-a276-d4ce0aec043a | 1 | 2012-07-24 |
| 60505-0191-1 | EA - Each | 60505-0191 | 67127d0f-93e3-4b1a-ba3f-a6824aad2c91 | 1 | 2012-07-24 |
| 60505-0191-4 | EA - Each | 60505-0191 | 095983ff-0106-4f19-b060-795e69cb9d76 | 1 | 2012-07-24 |
| 60505-0191-8 | EA - Each | 60505-0191 | bff41923-b4b5-4748-8638-0c739ab25cf0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trijardy XR | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 71873567-9594-452a-bb92-34a129adecac | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| INVOKAMET | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Janssen Pharmaceuticals, Inc. | 6868666b-c25e-40d1-9d1f-306bbe9390c1 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | ScieGen Pharmaceuticals Inc | 4e4c4ba9-65c6-4273-8f6b-2423ab521dad | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 073cf6d9-7142-4d8b-898e-174c62a1f76f | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Actoplus Met | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 42e49120-6f3f-11db-9fe1-0800200c9a66 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Saxagliptin and Metformin | SAXAGLIPTIN AND METFORMIN | Mylan Pharmaceuticals Inc. | cbf8677c-cafe-48bc-8844-0cc6547886bd | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | QPharma,Inc. | 5866ca12-a28f-cbe7-e063-6294a90acc69 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Jentadueto XR | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 4dcef36f-000e-43f5-8d67-0e2a079ab2c6 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCl | METFORMIN HCL | Unit Dose Solutions, Inc. | 5538e9df-0983-9281-e063-6394a90a9249 | 2026-08-18 | Warnings, Adverse reactions | 786Z46389E |
| KAZANO | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 83cb7914-a683-47bb-a713-f2bc6a596bd2 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | 58f0e875-5d9b-be0b-e063-6394a90a5345 | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Quallent Pharmaceuticals Health LLC | 25be863d-490c-47f6-9ad3-c828dc43fbf0 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 4d812277-21a8-4de3-b728-e3fdd01305b5 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and metformin hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | e07abcb1-1f0c-4cad-8405-8eedba4b8ff8 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| ZITUVIMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | 0098dec4-f0e5-45d5-8aa4-5d0faf9ab142 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| SEGLUROMET | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | a6aeb99a-ce49-4125-90ce-642df3f1ebad | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| JANUMET XR | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | 64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Redpharm Drug | 58bec665-b648-6baf-e063-6394a90a1cbb | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.